Post-doctoral fellow, Dynavax Technology
Berkeley, United States
Dr. Shu Wang received her Ph.D in Biochemistry, Microbiology and Molecular Biology from Penn State University in University Park, Pennsylvania. Prior to the PhD training, she received her BS and MS from China Pharmaceutical University. Dr. Wang is currently a post-doctoral fellow working on developing immunotherapies at Dynavax Technology. She serves as a reviewer for several scientific journals.
Cancer immunotherapy; TLR agonists; epigenetic enzyme inhibitor for cancer and autoimmune disease treatment; histone citrullination in eukaryotic gene regulation, chromatin folding and innate immunity.